A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
Status:
Recruiting
Trial end date:
2023-01-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness and safety of various nivolumab
combinations compared to nivolumab and ipilimumab in participants with advanced kidney cancer